These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Listed as ongoing, but also has a completion date||2004-003868-30||BTOG2: A British Thoracic Oncology Group phase III trial of gemcitabine plus cisplatin at 80 mg/m2 versus gemcitabine plus cisplatin at 50 mg/m2 versus gemcitabine plus carboplatin AUC 6 in stage IIIB...||2011-04-01||bad-data|
|Not reported Terminated||2006-005816-29||A Pilot Study of Taxotere (Docetaxel), Cisplatin and 5FU (TPF) in the Palliative Treatment of Squamous Cell Carcinoma of the Head and Neck||2011-02-15||due-trials|
|Not reported||2007-002169-11||Cost Analysis Of Cetuximab (Erbitux) Plus Radiotherapy (ERT) Versus Concomitant Cisplatin Plus Radiotherapy (CRT) Within An NHS Oncology Unit (New Cross Hospital Wolverhampton): A Pilot Study||2011-09-23||due-trials|
|Ongoing||2007-004085-41||Photodynamic Therapy for Basal Cell Carcinoma of the Eyelid and Periocular Skin with methyl aminolevulinate||not-yet-due|
|Ongoing||2007-005391-13||Cancer Oesophagus Gefitinib(COG) - Phase III randomised, double-blind, placebo-controlled trial of gefitinib (Iressa®) versus placebo in oesophageal cancer progressing after chemotherapy.||not-yet-due|
|Ongoing||2012-005666-35||Can Intravenous Iron Reduce Transfusion rates in Anaemic patients undergoing Cardiac Surgery||not-yet-due|
|Ongoing||2014-004238-25||Pharmacokinetics and Pharmacodynamics of Platelet P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention (PCI) for Acute Myocardial Infarction: A Pilot Study||not-yet-due|
|Ongoing||2016-000195-19||The Effect of Intravenous Cangrelor and Oral Ticagrelor on Platelets, the Microcirculation and Myocardial Damage in Patients admitted with STEMI Treated by Primary Percutaneous Coronary Intervention ...||not-yet-due|